These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14526781)

  • 1. Drug-resistant strains of HIV increase sharply in Japan. Health officials step up efforts to improve diagnosis and ensure adherence to treatment.
    McCurry J
    Lancet; 2003 Sep; 362(9389):1052. PubMed ID: 14526781
    [No Abstract]   [Full Text] [Related]  

  • 2. Adherence and HIV drug resistance.
    Sethi AK
    Hopkins HIV Rep; 2004 Jan; 16(1):6-8. PubMed ID: 14989193
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from the XV International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2006 Sep; 18(9):83-4. PubMed ID: 16995272
    [No Abstract]   [Full Text] [Related]  

  • 4. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 5. Are resistance puzzlers caught in a data quagmire? XIV International HIV Drug Resistance Workshop. June 7-11, 2005, Quebec, Canada.
    Mascolini M
    IAPAC Mon; 2005 Sep; 11(9):256-64, 267-75. PubMed ID: 16363042
    [No Abstract]   [Full Text] [Related]  

  • 6. The Role of Phylogenetics as a Tool to Predict the Spread of Resistance.
    Zhukova A; Cutino-Moguel T; Gascuel O; Pillay D
    J Infect Dis; 2017 Dec; 216(suppl_9):S820-S823. PubMed ID: 29029155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.
    Hattori J; Shiino T; Gatanaga H; Yoshida S; Watanabe D; Minami R; Sadamasu K; Kondo M; Mori H; Ueda M; Tateyama M; Ueda A; Kato S; Ito T; Oie M; Takata N; Hayashida T; Nagashima M; Matsuda M; Ibe S; Ota Y; Sasaki S; Ishigatsubo Y; Tanabe Y; Koga I; Kojima Y; Yamamoto M; Fujita J; Yokomaku Y; Koike T; Shirasaka T; Oka S; Sugiura W
    Antiviral Res; 2010 Oct; 88(1):72-9. PubMed ID: 20692295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV drug resistance in Africa: an emerging problem that deserves urgent attention.
    Moreno M; Caballero E; Mateus RM; Samba F; Gil E; Falcó V
    AIDS; 2017 Jul; 31(11):1637-1639. PubMed ID: 28481772
    [No Abstract]   [Full Text] [Related]  

  • 10. Accrued HIV evidence turns treatment dogma on its head.
    Check E
    Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150
    [No Abstract]   [Full Text] [Related]  

  • 11. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV in Europe--a growing threat.
    Wahren B
    J Clin Virol; 2001 May; 21(2):171-3. PubMed ID: 11417524
    [No Abstract]   [Full Text] [Related]  

  • 13. The K65R mutation: selection, frequency, and possible consequences.
    Moyle GJ
    AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance studies from the 10th Conference on Retroviruses and Opportunistic Infections.
    Boyle BA
    AIDS Read; 2003 Apr; 13(4):166-71. PubMed ID: 12741367
    [No Abstract]   [Full Text] [Related]  

  • 15. Report from the XVII International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2008 Aug; 20(8):61-2. PubMed ID: 18814368
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical data marshalled to treat HIV.
    Clarke T
    Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390
    [No Abstract]   [Full Text] [Related]  

  • 17. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco.
    Smith RJ; Okano JT; Kahn JS; Bodine EN; Blower S
    Science; 2010 Feb; 327(5966):697-701. PubMed ID: 20075214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS. Tangled patent dispute over 'free' drug-resistance database.
    Cohen J
    Science; 2009 Feb; 323(5918):1156-7. PubMed ID: 19251598
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV drug resistance and you. Resistance overview. A look at the basics.
    Munk B
    Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502
    [No Abstract]   [Full Text] [Related]  

  • 20. In Defense of Baseline Genotypic Antiretroviral Resistance Testing.
    Lang R; Krentz HB; Gill MJ
    J Acquir Immune Defic Syndr; 2020 Jan; 83(1):e1-e2. PubMed ID: 31809365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.